Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Deerfield Group
Built for This: Deerfield Group Expands Leadership to Advance Next Phase of Growth, Harnessing Innovation, Technology Anchored in Human Expertise
September 15, 2026
DEERFIELD GROUP ANNOUNCES STRATEGIC INVESTMENT FROM MARTIS CAPITAL TO FUEL NEXT PHASE OF GROWTH
June 30, 2026
Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026
HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
April 28, 2026
Deerfield Group Launches Prismatiq™, an Intuitive Field Enablement Platform Purpose-Built for Life Sciences
April 22, 2026
Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
April 17, 2026
Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting
April 17, 2026
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
April 17, 2026
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
April 9, 2026
Deerfield Group Names Bill Veltre as Chief Media Officer
April 9, 2026
1
2
Next Page
→